Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA News In Brief

This article was originally published in The Gray Sheet

Executive Summary

OC strategic plan oversight: CDER Director Janet Woodcock, detailed to the Office of the Commissioner starting Oct. 20, will facilitate implementation of cross-cutting initiatives at agency centers, Oct. 7 FDA memo indicates. Although the detail is set for six months, it could evolve into a longer-term position. In the memo, the agency also announces plans to create a strategic plan council and regulatory policy council and to hold bimonthly "two on twos" between the commissioner/deputy commissioner and center directors/deputy center directors in lieu of executive council meetings...

You may also be interested in...



FDA External Relations Head Pitts Will Leave Agency For New York PR Firm

FDA Associate Commissioner for External Relations Peter Pitts is leaving after 14 months at the agency to join the public relations firm Manning, Selvage & Lee

FDA External Relations Head Pitts Will Leave Agency For New York PR Firm

FDA Associate Commissioner for External Relations Peter Pitts is leaving after 14 months at the agency to join the public relations firm Manning, Selvage & Lee

Acting Commish II: Crawford Assumes FDA Helm As McClellan Heads To CMS

FDA Deputy Commissioner Lester Crawford, PhD, will head a reorganized agency following Commissioner Mark McClellan's move to the Centers for Medicare & Medicaid Services

Related Content

UsernamePublicRestriction

Register

OM016204

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel